CTMS
Integrated Clinical Trial Management
Manage Clinical Trials from Protocol Approval to the Study Closeout through an integrated CTMS on the CARA Life Sciences Platform™. CTMS enables the consistent use of the Study Protocol and Study Master Data along the entire Clinical Trial operations value chain.
Our CTMS provides a single source of truth for all operational Clinical Trial data and workflows. It helps Clinical Trial Managers to make operational decisions based on timely, accurate and consistent data consolidated across simultaneous workstreams like study and site initiation, patient recruitment, monitoring and drug supply.
Reach Across the Organisation
Connect all clinical trial operation workflows through CTMS data & master data.
Align Disparate Workstreams
CTMS on the CARA Life Sciences Platform is the single source of truth for operational data, integrating multiple systems and processes.
Adapt to Evolving Regulations
Conduct clinical trails by adapting the latest regulations to the advantage and safety of enrolled patients.
Data Interoperability
The UI is common between all business processes, reducing training and improving adoption.
Collaboration
Clinical Trial end-to-end support
Cara CTMS enables overarching collaboration across sponsor organisations, regulators, sites, investigators, participants, monitors, CRA’s, and 3rd parties.
Such collaboration maintains and manages all aspects of Clinical Trials including planning, performance reporting, information sharing, tracking of timelines and milestones across a single platform.
Features
Clinical Program / Project Management
Trial and Site Planning
Trial Design
Site and Subject Management
Study Management
Investigator Management
Clinical Supply Tracking
Clinical Trial Performance and Reporting
Latest Resources
From Months to Minutes: Can AI Really Transform Regulatory Submissions?
From Months to Minutes: Can AI Really Transform Regulatory Submissions? For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions CARA Life Sciences Platform Adoption Continues to Grow with Biotech Organisation
CARA Platform Migration Guide with DAQUMA
We know that migrating from complex, entrenched legacy systems can be daunting – especially when you’re managing large volumes of data and critical processes. That’s
Contact
External Collaboration
Use the tools in CARA to invite users to a time-limited access to the CARA Life Science platform to collaborate on individual document(s). This collaboration is in a secure environment with version control and auditing. The collaboration can include review or collaborative authoring, where multiple users can edit the same document at the same time
